Recombinantly produced human factor VIII and IX

Details for Australian Patent Application No. 2009284113 (hide)

Owner Octapharma AG

Inventors Sandberg, Helena; Stenlund, Peter; Schroder, Carola; Casademunt, Elisabeth; Tiemeyer, Maya

Agent Davies Collison Cave

Pub. Number AU-A-2009284113

PCT Pub. Number WO2010/020690

Priority 08162765.5 21.08.08 EP; 61/136,250 21.08.08 US

Filing date 21 August 2009

Wipo publication date 25 February 2010

International Classifications

C07K 14/755 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07K 14/745 (2006.01) Peptides having more than 20 amino acids

Event Publications

10 February 2011 PCT application entered the National Phase

  PCT publication WO2010/020690 Priority application(s): WO2010/020690

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009284114-Measuring and monitoring mental capacity

2009284102-High performance water based fluids